SQLite Web: event

id

Primary key. TEXT

event_id

TEXT NOT NULL

watcher_id

TEXT

signal_type

TEXT NOT NULL

value

{"aggregator_url":"https://www.nasdaq.com/articles/what-makes-healthcare-stock-worth-holding-through-recession","as_of":"2026-04-14T21:50:00.113245+00:00","canonical_url":"https://www.fool.com/investing/2026/04/14/what-makes-healthcare-stock-worth-hold-recession/","enrichment":{"aggregator_url":"https://www.nasdaq.com/articles/what-makes-healthcare-stock-worth-holding-through-recession","article_chars":4081,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_a682e1b2ca2e85f7","canonical_host":"fool.com","canonical_is_aggregator":false,"canonical_url":"https://www.fool.com/investing/2026/04/14/what-makes-healthcare-stock-worth-hold-recession/","content_type":"text/html; charset=utf-8","enriched_at":"2026-04-15T17:33:57.629174+00:00","extraction_method":"trafilatura","fetched_description":"Key PointsHealthcare may be considered a defensive sector, but not all healthcare stocks make for strong defensive plays.","fetched_title":"What Makes a Healthcare Stock Worth Holding Through a Recession? | Nasdaq","final_url":"https://www.nasdaq.com/articles/what-makes-healthcare-stock-worth-holding-through-recession","html_truncated":false,"paywall_likely":false,"publisher_domain":"fool.com","publisher_resolution":"canonical_url","requested_url":"https://www.nasdaq.com/articles/what-makes-healthcare-stock-worth-holding-through-recession","source_event_id":"evt_44f4ac90989c","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"fp":"77b71f54076e804a","kind":"unusual_volume","published_at":"2026-04-14T20:59:00+00:00","publisher_domain":"fool.com","signal_understanding":{"analysis_basis":"article","claim_confidence":0.74,"dates_mentioned":["last year","December 17, 2004","April 15, 2005","April 14, 2026"],"entities":[{"asset_class":"equity","name":"Becton, Dickinson and Company","relevance":"high","symbol":"BDX","type":"company"},{"asset_class":"equity","name":"Johnson & Johnson","relevance":"high","symbol":"JNJ","type":"company"},{"asset_class":"equity","name":"Nvidia","relevance":"low","symbol":"N/A","type":"company"},{"asset_class":"equity","name":"Intel","relevance":"low","symbol":"N/A","type":"company"},{"asset_class":"other","name":"Morningstar (analyst Karen Anderson)","relevance":"medium","symbol":"N/A","type":"organization_person"}],"event_type":"other","information_gaps":["No unusual trading volume data is provided in the text (no ticker, no volume ratio vs average, no direction, and no baseline volume).","The signal type indicates unusual volume delta, but the article content is a general investment thesis and does not mention any volume spike or confirmation by news.","No explicit catalyst for any volume change is described; the article discusses recession-resilience criteria rather than a specific event."],"key_facts":["The article states healthcare may be considered defensive, but not all healthcare stocks are strong defensive plays.","It recommends focusing on healthcare companies with wide economic moats and strong balance sheets to assess recession strength.","It says discretionary healthcare spending (e.g., elective surgeries, preventative care, cosmetic treatments) tends to take a back seat during slowdowns and recessions.","It claims hospitals rely on Becton Dickinson\u2019s medical supplies, lab equipment, and diagnostic products during both booms and busts.","It states Johnson & Johnson has one of the widest moats among healthcare names, primarily due to moats in its medical technology and pharmaceutical segments (as noted by Morningstar analyst Karen Anderson).","It says high debt adds greater risk during downturns and references debt-to-equity and debt-to-EBITDA as proxies for financial strength.","It states both Becton Dickinson and Johnson & Johnson have debt-to-equity ratios below 1.","It states both are Dividend Kings, with 54 and 64 years of annual dividend growth, respectively."],"numeric_claims":[{"label":"BDX dividend growth years (Dividend King)","value":"54"},{"label":"JNJ dividend growth years (Dividend King)","value":"64"},{"label":"Debt-to-equity ratio threshold","value":"below 1 (for both BDX and JNJ)"}],"primary_claim":"Healthcare stocks are not uniformly recession-resistant; the article recommends selecting healthcare companies with wide economic moats and strong balance sheets, citing Becton Dickinson (BDX) and Johnson & Johnson (JNJ) as strong examples.","relevance_score":0.22,"sentiment":"mixed","source_quality":"high","summary":"The article argues that healthcare can be defensive in recessions, but investors should prefer healthcare companies with wide economic moats and strong balance sheets. It highlights Becton Dickinson (BDX) and Johnson & Johnson (JNJ) as examples, citing their recession-resilient demand and financial strength.","topics":["healthcare sector defensiveness","economic moats","balance sheet strength","recession-resistant demand","medical devices","pharmaceuticals","dividend growth"]},"source":"Nasdaq Markets","source_domain":"fool.com","summary":"Key PointsHealthcare may be considered a defensive sector, but not all healthcare stocks make for strong defensive plays.","tickers":[],"title":"What Makes a Healthcare Stock Worth Holding Through a Recession?","url":"https://www.fool.com/investing/2026/04/14/what-makes-healthcare-stock-worth-hold-recession/"}

TEXT NOT NULL

threshold

TEXT

direction

TEXT

severity

TEXT

window

TEXT

source

TEXT NOT NULL

reason_trace

TEXT

dedupe_key

TEXT NOT NULL

throttle_s

INTEGER (default 0

created_at

TEXT NOT NULL (default strftime('%Y-%m-%dT%H:%M:%fZ','now')

event_store.db — signals

Update row sig_0212fdef9612 in signals